Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Cdc20: a potential novel therapeutic target for cancer treatment.

Cdc20: a potential novel therapeutic target for cancer treatment. Curr Pharm Des. 2013; 19(18):3210-4.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.